期刊文献+

剪切波弹性成像和血清肝纤维化标志物检测对婴儿肝炎综合征肝纤维化的预测价值 被引量:1

Predictive Value of Shear Wave Elastography and Serum Markers of Hepatic Fibrosis in Hepatic Fibrosis of Infantile Hepatitis Syndrome
在线阅读 下载PDF
导出
摘要 【目的】探讨剪切波弹性成像(SWE)和血清肝纤维化标志物在预测婴儿肝炎综合征(IHs)肝纤维化的应用价值。【方法】选择2016年3月至2017年5月在本院确诊的婴儿IHS60例作为研究对象,按照慢性肝炎纤维化分期标准分为S1~4期,选取同期体检的20名健康婴儿为对照组。采用SWE检测患儿肝硬度(LS),同时检测患儿血清肝纤维化标志物水平。【结果】患儿年龄、血红蛋白(HB)、总胆红素(TB)、透明质酸(HA)、Ⅳ型胶原(Ⅳ-C)、LS与肝纤维化程度具有显著的相关性(P〈0.05),HB与肝纤维化呈显著负相关,其他均为显著正相关。HA、Ⅳ-C、LS与肝纤维化呈极显著正相关(P〈0.01)。天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和γ-谷氨酰转肽酶(GGT)与肝纤维化分期之间没有显着相关性(P〉0.05)。与HA和Ⅳ-C相比,使用SWE检测LS在轻度纤维化、中度纤维化和重度纤维化分析中均具有最高的曲线下面积,依次为0.866、0.904和0.893。在轻度纤维化ROc曲线分析中,HA曲线下面积(0.837)大于Ⅳ-C(0.716),而在中度纤维化和高度纤维化ROC曲线分析中,Ⅳ-C曲线下面积分别为0.812和o.854,均分别高于HA(0.722和0.830)。[结论]SWE和血清肝纤维化标志物(HA和Ⅳ-C)在婴儿IHs肝纤维化方面均具有良好的诊断效能,SWE要优于血清肝纤维化标志物。 [Objective] To investigate the value of shear wave elastography (SWE) and serum markers of hepatic fibrosis in predicting hepatic fibrosis in infantile hepatitis syndrome (IHS). [Methods] Sixty infants with IHS diagnosed in our hospital from March 2016 to May 2017 were selected as the subjects, According to the staging criteria of chronic hepatitis fibrosis, it is divided into S1-4 stage, At the same time, 20 healthy infants were selected as control group. Liver stiffness (LS) was detected by SWE, and serum markers of liver fibrosis were detected in children.[Results]Age, hemoglobin (HB), total bilirubin (TB), hyaluronic acid (HA), type IV collagen (IV -C), LS were significantly correlated with the degree of liver fibrosis (P 0.05), and HB was negatively correlated with liver fibrosis, and the others were significantly positively correlated. There was a significant positive correlation between HA, IV-C, LS and liver fibrosis ( P〈0.01). Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma glutamyl transferase (GGT) were not significantly correlated with liver fibrosis stages ( P 〈0.05). Compared with HA and IV-C, the detection of LS with SWE showed the highest curve area in mild fibrosis, moderate fibrosis and severe fibrosis analysis, followed by 0.866,0.904 and 0.893. In the ROC curve analysis of mild fibrosis, the area under the HA curve (0.837) was greater than that of IV-C (0.716), In the ROC curve of moderate fibrosis and high fibrosis, the area under the IV-C curve was 0.812 and 0.854, respectively, which were higher than those of HA (0.722 and 0.830) respectively.[Conclusion]SWE and serum markers of liver fibrosis (HA and IV-C) have good diagnostic efficacy in infants with IHS liver fibrosis, and SWE is superior to serum markers of liver fibrosis.
机构地区 湖南省儿童医院
出处 《医学临床研究》 CAS 2017年第11期2116-2119,2123,共5页 Journal of Clinical Research
关键词 弹性成像技术/方法 肝硬化/血液 肝炎/血液 生物学标记/血液 综合征 Elasticity Imaging Techniques/MT Liver Cirrhosis/BL Hepatitis/BL Biological Markers/BL Syndrome
  • 相关文献

参考文献6

二级参考文献96

  • 1吴朝栋.细胞因子与肝纤维化发病机制研究进展[J].国外医学(消化系疾病分册),1995,15(2):93-95. 被引量:6
  • 2丁效蕙,赵景民,孙艳玲,周光德,潘登,杨建法,赵雨来.非酒精性脂肪性肝炎肝组织TNF-α、TGF-β_1和Leptin的表达及意义[J].解放军医学杂志,2006,31(8):750-750. 被引量:6
  • 3张勇,尹纪业,宋良文,王清明,王晓民.肝再生增强因子抑制肝非实质细胞TGF-β_1表达的意义[J].解放军医学杂志,2006,31(9):896-898. 被引量:5
  • 4Bravo AA, Sheth SG, Chopra S. Liver biopsy. NEngl J Med 2001; 344: 495-500.
  • 5Abdi W, Millan JC, Mezey E. Sampling variability on percu- taneous liver biopsy. Arch Intern Med 1979; 139: 667-669.
  • 6Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
  • 7Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481.
  • 8Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ. Sampling variability and its influ- ence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525.
  • 9Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
  • 10Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-Lyon I, Williams R. Noninvasive markers of fibrosis and inflamma- tion in clinical practice: prospective comparison with liver biopsy. Eur J GastroenterolHepatol 2010; 22: 474-480.

共引文献150

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部